The changing face of patents in generic pharmaceutical development: Facts and figures

摘要

Anyone who has been involved in developmet of generic pharmaceuticals over the past 10-15 years will be well aware of the increase in importance of patents over that period. It may seem clear to those heavily involved in investigating the patent landscape and forming corresponding development strategies that their role has become more complex. But it is possible that the overwhelming amount of patent-related issues faced by such executives prevents them form understanding exactly what is changing and why.